Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Can the Blood Urea Nitrogen to Serum Albumin Ratio Predict a Prolonged Hospital Stay in Patients with Acute Cholecystitis?

Abuzer Özkan,Kadir Özsivri,Abdullah Algın,Serdar Özdemir.




Abstract

Aim: The gallbladder inflammation with or without stones is acute cholecystitis. The blood urea nitrogen to serum albumin ratio (BAR) is a biomarker of acute pulmonary embolism, pneumonia, critical illness, and prognostic mortality in geriatric patients. We evaluated the predictive ability of BAR for prolonged hospital stay in acute cholecystitis.
Materials and Methods: This study was designed retrospectively and evaluated data collected at an emergency department from January 5, 2022, through April 5, 2022. A seven-day hospitalization period was determined as the limit for long-term hospitalization, with the patients staying in the hospital for eight days or longer being included in the prolonged hospital stay group.
Results: The study was conducted over the data of 220 patients. The mean age (25th-75th percentile) was 59.0 (43.8-71.0) years, and 109 (50 %) patients were female. During the one-month follow-up, four (2 %) patients died. In total, 86 patients underwent surgery. The odds ratio was determined as 4.88 [95% confidence interval (CI): 1.66-14.37, p=0.002] for BAR, 2.81 (95% CI: 1.36-5.78, p=0.004) for blood urea nitrogen, and 0.13 (95% CI: 0.04-0.38, p

Key words: Albumin, acute cholecystitis, blood urea nitrogen, length of stay






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.